NASDAQ:CHNG - Change Healthcare Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $22.77
  • Forecasted Upside: -1.25 %
  • Number of Analysts: 20
  • Breakdown:
  • 0 Sell Ratings
  • 15 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$23.06
▼ -0.09 (-0.39%)

This chart shows the closing price for CHNG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Change Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHNG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHNG

Analyst Price Target is $22.77
▼ -1.25% Downside Potential
This price target is based on 20 analysts offering 12 month price targets for Change Healthcare in the last 3 months. The average price target is $22.77, with a high forecast of $25.75 and a low forecast of $15.00. The average price target represents a -1.25% upside from the last price of $23.06.

This chart shows the closing price for CHNG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 20 contributing investment analysts is to hold stock in Change Healthcare. This rating has held steady since December 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 11 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 15 hold ratings
  • 0 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 15 hold ratings
  • 0 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 15 hold ratings
  • 0 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 15 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/10/2021JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
1/11/2021Berenberg BankDowngradeBuy ➝ Hold$23.00 ➝ $25.75Low
1/7/2021Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$25.75Low
1/7/2021Cantor FitzgeraldDowngradeOverweight ➝ Neutral$25.75Low
1/7/2021Wells Fargo & CompanyDowngradeOverweight ➝ Equal WeightLow
1/7/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellDowngradeBuy ➝ NeutralN/A
1/7/2021CowenDowngradeOutperform ➝ Market PerformN/A
1/7/2021TruistDowngradeBuy ➝ HoldN/A
1/7/2021Smith Barney CitigroupDowngradeBuy ➝ NeutralN/A
1/7/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$25.75N/A
1/7/2021Credit Suisse GroupDowngradeOutperform ➝ Neutral$25.75N/A
1/6/2021GuggenheimDowngradeBuy ➝ NeutralN/A
1/6/2021Robert W. BairdDowngradeOutperform ➝ NeutralN/A
1/6/2021Raymond JamesDowngradeStrong-Buy ➝ Market PerformN/A
1/6/2021Piper SandlerBoost Price TargetOverweight$23.00 ➝ $25.75N/A
1/6/2021William BlairDowngradeOutperform ➝ Market PerformN/A
12/15/2020SVB LeerinkBoost Price TargetOutperform$19.00 ➝ $22.00Low
12/8/2020Berenberg BankInitiated CoverageBuy$23.00Low
11/25/2020Smith Barney CitigroupBoost Price Target$19.00 ➝ $22.00Low
11/9/2020Credit Suisse GroupBoost Price TargetOutperform$19.00 ➝ $22.00Low
11/9/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$16.00 ➝ $18.00High
11/6/2020Smith Barney CitigroupBoost Price Target$18.00 ➝ $19.00Low
11/5/2020Cantor FitzgeraldBoost Price TargetOverweight$17.00 ➝ $18.00Low
9/28/2020CSFBBoost Price TargetOutperform$16.00 ➝ $19.00Low
9/28/2020Credit Suisse GroupBoost Price TargetOutperform$16.00 ➝ $19.00Low
9/14/2020CitigroupBoost Price TargetBuy$16.00 ➝ $18.00Low
8/7/2020SVB LeerinkBoost Price TargetOutperform$13.00 ➝ $15.00High
8/6/2020Piper SandlerBoost Price TargetOverweight$19.00 ➝ $22.00Medium
7/14/2020CitigroupInitiated CoverageBuy$15.00High
7/6/2020Bank of AmericaReiterated RatingBuy$15.00High
6/8/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$12.00 ➝ $14.00Low
6/5/2020SunTrust BanksBoost Price TargetBuy$15.00 ➝ $17.00Medium
5/6/2020Credit Suisse GroupReiterated RatingBuy$16.00Medium
4/22/2020SunTrust BanksLower Price TargetBuy$17.00 ➝ $15.00Low
4/17/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$17.00 ➝ $12.00Low
4/13/2020Bank of AmericaBoost Price TargetBuy$13.00 ➝ $14.00Low
4/13/2020Credit Suisse GroupLower Price TargetOutperform$17.00 ➝ $16.00High
4/13/2020SVB LeerinkInitiated CoverageOutperform$13.00Medium
4/9/2020BarclaysLower Price TargetOverweight$18.00 ➝ $14.00Low
3/26/2020SunTrust BanksLower Price TargetBuy$21.00 ➝ $17.00High
3/18/2020The Goldman Sachs GroupReiterated RatingBuyHigh
3/18/2020Credit Suisse GroupLower Price TargetOutperform$21.00 ➝ $17.00High
3/18/2020Raymond JamesUpgradeOutperform ➝ Strong-Buy$20.00High
3/10/2020Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$19.00Medium
2/14/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$15.00 ➝ $17.00Low
1/10/2020GuggenheimReiterated RatingBuy$20.00Low
1/8/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$14.00 ➝ $17.00Low
12/19/2019Raymond JamesInitiated CoverageOutperform$18.00Medium
11/27/2019Royal Bank of CanadaInitiated CoverageOutperform$16.00N/A
11/21/2019Royal Bank of CanadaInitiated CoverageOutperform$16.00Low
9/26/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy$15.00Low
7/22/2019Robert W. BairdInitiated CoverageOutperform ➝ Outperform$18.00Medium
7/22/2019William BlairInitiated CoverageOutperform ➝ OutperformLow
7/22/2019SVB LeerinkInitiated CoverageOutperform ➝ Outperform$20.00High
7/22/2019Credit Suisse GroupInitiated CoverageOutperform ➝ Outperform$18.00High
7/22/2019SunTrust BanksInitiated CoverageBuy ➝ Buy$21.00High
7/22/2019GuggenheimInitiated CoverageBuy ➝ Buy$17.00High
7/22/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$18.00High
7/22/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$19.00High
7/22/2019Wells Fargo & CompanyInitiated CoverageMarket Perform ➝ Market PerformHigh
7/22/2019CitigroupInitiated CoverageBuy ➝ Buy$22.00High
7/22/2019The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$20.00High
7/22/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$18.50High
7/22/2019CowenInitiated CoverageOutperform ➝ Outperform$17.00High
7/22/2019Cantor FitzgeraldInitiated CoverageOverweight ➝ Overweight$20.00High
7/22/2019BarclaysInitiated CoverageOverweight ➝ Overweight$18.00High
(Data available from 6/24/2016 forward)
Change Healthcare logo
Change Healthcare Inc., an independent healthcare technology company, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment offers software and analytics solutions for revenue cycle management, provider network management, payment accuracy, clinical decision support, value-based payment, consumer engagement, risk adjustment and quality performance, and imaging and clinical workflow. The Network Solutions segment provides solutions for financial, administrative, and clinical and pharmacy transactions; connected consumer health; intelligent healthcare network; electronic business-to-business and consumer-to-business payments; data; and aggregation and analytics of clinical and financial data. The Technology-Enabled Services segment offers solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration, and healthcare consulting. The company serves commercial insurers, private insurers, BlueCross Blue Shield plans, Medicare/Medicaid plans, provider-sponsored payers, third party administrators, emerging technology and data-driven health plans, and other specialty health benefits insurers, as well as hospitals and health systems, physician practices, dentists, pharmacies, skilled nursing facilities, home health agencies, telehealth providers, senior care facilities, laboratories, and other healthcare providers. Change Healthcare Inc. was incorporated in 2016 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $23.06
Low: $23.03
High: $23.27

50 Day Range

MA: $23.10
Low: $22.36
High: $23.68

52 Week Range

Now: $23.06
Low: $9.76
High: $24.21

Volume

819,845 shs

Average Volume

3,801,352 shs

Market Capitalization

$7.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Frequently Asked Questions

What sell-side analysts currently cover shares of Change Healthcare?

The following Wall Street research analysts have issued research reports on Change Healthcare in the last twelve months: Bank of America Co., Berenberg Bank, Cantor Fitzgerald, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, Cowen Inc, Credit Suisse Group AG, CSFB, Deutsche Bank Aktiengesellschaft, Guggenheim, JPMorgan Chase & Co., Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Smith Barney Citigroup, SVB Leerink LLC, Truist, Wells Fargo & Company, William Blair, and Zacks Investment Research.
View the latest analyst ratings for CHNG.

What is the current price target for Change Healthcare?

11 Wall Street analysts have set twelve-month price targets for Change Healthcare in the last year. Their average twelve-month price target is $22.77, suggesting a possible downside of 1.2%. Royal Bank of Canada has the highest price target set, predicting CHNG will reach $25.75 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $15.00 for Change Healthcare in the next year.
View the latest price targets for CHNG.

What is the current consensus analyst rating for Change Healthcare?

Change Healthcare currently has 15 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CHNG, but not buy more shares or sell existing shares.
View the latest ratings for CHNG.

What other companies compete with Change Healthcare?

How do I contact Change Healthcare's investor relations team?

Change Healthcare's physical mailing address is 3055 Lebanon Pike Suite 1000, NASHVILLE TN, 37214. The company's listed phone number is 615-932-3000 and its investor relations email address is [email protected] The official website for Change Healthcare is www.changehealthcare.com.